Selventa Strengthens Intellectual Property for SysDx™ Approach to Personalized Medicine
Thursday, May 09, 2013
Patent is core to Selventa’s SysDx™ approach to mining and comparing biological data for predicting a patient’s response or non-response to a drug.
Sydney Based Cellmid Acquires Japanese Advangen
Thursday, May 09, 2013
Strategic acquisition of Japanese healthcare company boosts Cellmid’s cashflow potential.
TriLink BioTechnologies Announces Worldwide License with QuantiBact A/S
Thursday, May 09, 2013
TriLink BioTechnologies Inc. announced that it has signed a licensing agreement with QuantiBact A/S to offer twisted intercalating nucleic acid (TINA) modified oligos.
New Lung Cancer Guidelines Recommends Offering Screening to High-Risk Individuals
Wednesday, May 08, 2013
Advances in treatment have major impact on short- and long-term outcomes.
Analytik Jena Establishes Subsidiary in Thailand
Tuesday, May 07, 2013
New company to bolster Analytik Jena’s activities in the Southeast Asian market.
Analytik Jena to Develop Products for Sepsis Diagnostics
Tuesday, May 07, 2013
Cooperation to continue with the scientific centers for sepsis research in Jena.
Analytik Jena to Develop Products for Sepsis Diagnostics
Tuesday, May 07, 2013
Integration of a core team of former employees in the Life Science business unit. Cooperation to continue with the scientific centers for sepsis research in Jena.
Medical Diagnostics Company STAT-Diagnostica Secures $22.1 Million in Financing
Tuesday, May 07, 2013
Proceeds will be used to complete development of the company’s Near Patient Testing diagnostic system and clinical validation of its first products.
Genomic Analysis of Endometrial Tumors
Tuesday, May 07, 2013
Genomic classification of endometrial tumors could help guide treatment strategies, according to a new analysis.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 21 - 30 of 1018 |
|
|
